SS-31 and Cardiolipin: How a Mitochondria-Targeted Tetrapeptide Works
SS-31, also known as elamipretide, is unusual among research peptides because its mechanism is defined by where it goes rather than by a receptor it binds. It is one of a small family of mitochondria-targeted tetrapeptides.
The targeting motif
The SS peptides share an alternating aromatic-cationic sequence. That pattern gives the molecule a net positive charge at physiological pH combined with aromatic residues, and the combination drives accumulation in the inner mitochondrial membrane. Importantly, uptake is described in the literature as largely independent of membrane potential, which distinguishes SS peptides from earlier cationic mitochondrial probes whose accumulation collapses when the membrane depolarises.
Cardiolipin as the binding partner
Cardiolipin is a four-tailed phospholipid essentially confined to the inner mitochondrial membrane, where it is required for the structural organisation of the electron transport chain complexes and for cristae architecture. SS-31 associates with cardiolipin rather than with a protein receptor.
The proposed consequence in the literature is that binding stabilises cardiolipin-dependent supercomplex organisation and reduces the peroxidase activity that cardiolipin acquires when it complexes with cytochrome c. Both are structural rather than signalling effects, which is why SS-31 is often described as a membrane-interacting agent instead of an agonist. The primary literature is indexed at PubMed and here for elamipretide.
Why this matters for assay design
A compound with no receptor has no binding assay. Studies in this area therefore rely on functional mitochondrial readouts: oxygen consumption rate, membrane potential dyes, supercomplex assembly by blue native PAGE, or cristae morphology by electron microscopy. Concentration-response relationships in such systems are frequently non-monotonic, and choosing a single concentration on the basis of another study’s conditions is a common source of irreproducibility.
Related mitochondrial compounds
MOTS-c is often studied alongside SS-31 but is mechanistically unrelated — it is a mitochondrial-derived peptide encoded in the mitochondrial genome, acting largely through nuclear signalling rather than membrane association. Treating the two as a single category obscures that difference. Both, along with NAD-related compounds, are listed under mitochondrial and cellular compounds; we cover the distinction further in our note on MOTS-c and SS-31.
Handling
SS-31 is supplied lyophilised. As with other short cationic peptides, adsorption to glass and plastic surfaces at low concentrations is a genuine practical issue and can produce apparent potency differences between laboratories using different labware. Storage and reconstitution guidance is covered in our storage and stability note. Product page: SS-31 10mg.
ExoLabz supplies compounds for laboratory research use only. Nothing on this page is medical advice or a suggestion of human or veterinary use. Certificates of analysis for each compound are published on this site.
